1-9 of 9
Maria-Novella Piersantelli
Close
Sort by
Journal Articles

Line Treatment of Adult Ph+ Acute Lymphoblastic Leukemia (ALL) Patients. Final Results of the GIMEMA LAL1205 Study

Robert Foà, Antonella Vitale, Anna Guarini, Maria Sefania De Propris, Loredana Elia, Giuseppe Cimino, Mario Luppi, Carlo Castagnola, Simona Sica, Rosa Nieddu, Maria-Novella Piersantelli, Felicetto Ferrara, Francesco Nobile, Renato Fanin, Francesco Fabbiano, Marco Vignetti, Paola Fazi, Simona Soverini, Franco Mandelli, Giovanni Martinelli, Giovanna Meloni, Michele Baccarani
Journal: Blood
Blood (2008) 112 (11): 305.
https://doi.org/10.1182/blood.V112.11.305.305
Published: 2008
Journal Articles

ThaDD Regimen for Patients with Multiple Myeloma Aged ≥ 65 Years: An Update of the First 50 Patients Enrolled

Massimo Offidani, Laura Corvatta, Claudia Polloni, Maria-Novella Piersantelli, Silvia Gentili, Piero Galieni, Giuseppe Visani, Francesco Alesiani, Massimo Catarini, Marino Brunori, Arduino Samori, Maurizio Burattini, Riccardo Centurioni, Mario Ferranti, Luciano Giuliodori, Marco Candela, Anna Mele, Monica Marconi, Attilio Olivieri, Pietro Leoni
Journal: Blood
Blood (2008) 112 (11): 5186.
https://doi.org/10.1182/blood.V112.11.5186.5186
Published: 2008
Journal Articles

Role of Previous Thalidomide Administration on Final Outcome for 72 Patients with Relapsed Multiple Myeloma (MM) Treated with Bortezomib–Based Therapy

Massimo Offidani, MD, Laura Corvatta, Claudia Polloni, Maria-Novella Piersantelli, Silvia Gentili, Miriana Ruggieri, Lara Malerba, Francesco Alesiani, Massimo Catarini, Marino Brunori, Arduino Samori, Maurizio Burattini, Luisa Minnucci, Anna Mele, Monica Marconi, Pietro Leoni
Journal: Blood
Blood (2008) 112 (11): 5191.
https://doi.org/10.1182/blood.V112.11.5191.5191
Published: 2008
Journal Articles

Safety and Efficacy of ThaDD Regimen in Very Elderly Patients with Multiple Myeloma (MM)

Massimo Offidani, MD, Laura Corvatta, Maria-Novella Piersantelli, Claudia Polloni, Silvia Gentili, Piero Galieni, Giuseppe Visani, Francesco Alesiani, Massimo Catarini, Marino Brunori, Arduino Samori, Maurizio Burattini, Riccardo Centurioni, Mario Ferranti, Luciano Giuliodori, Marco Candela, Monica Marconi, Anna Mele, Pietro Leoni
Journal: Blood
Blood (2008) 112 (11): 5196.
https://doi.org/10.1182/blood.V112.11.5196.5196
Published: 2008
Journal Articles

ThaDD-V Treatment for Patients with Relapsed/Refractory Multiple Myeloma: A Feasibility/Activity Study.

Massimo Offidani, MD, Claudia Polloni, MD, Laura Corvatta, MD, Maria-Novella Piersantelli, MD, Anna Mele, MD, Massimo Catarini, MD, Marino Brunori, MD, Mario Ferranti, MD, Barbara Amoroso, MD, Pietro Leoni, PhD
Journal: Blood
Blood (2007) 110 (11): 2729.
https://doi.org/10.1182/blood.V110.11.2729.2729
Published: 2007
Journal Articles

Thalidomide-Dexamethasone vs Interferon-α-Dexamethasone as Maintenance Treatment after ThaDD Induction for Multiple Myeloma (MM): Final Analysis of a Prospective, Randomized Study.

Massimo Offidani, MD, Claudia Polloni, MD, Laura Corvatta, MD, Maria-Novella Piersantelli, MD, Piero Galieni, MD, Giuseppe Visani, MD, Francesco Alesiani, MD, Massimo Catarini, MD, Marino Brunori, MD, Maurizio Burattini, MD, Riccardo Centurioni, MD, Mario Ferranti, MD, Luciano Giuliodori, MD, Marco Candela, MD, Anna Mele, MD, Monica Marconi, MD, Pietro Leoni, PhD
Journal: Blood
Blood (2007) 110 (11): 532.
https://doi.org/10.1182/blood.V110.11.532.532
Published: 2007
Journal Articles

Thalidomide-Dexamethasone (Thal-dex) vs Interferon-α-Dexamethasone (IFN-dex) as Maintenance Treatment after ThaDD Induction for Multiple Myeloma (MM): First Analysis of a Prospective Randomized Study.

Massimo Offidani, MD, Laura Corvatta, MD, Claudia Polloni, MD, Maria-Novella Piersantelli, MD, Piero Galieni, MD, Giuseppe Visani, MD, Francesco Alesiani, MD, Massimo Catarini, MD, Marino Brunori, MD, Maurizio Burattini, MD, Riccardo Centurioni, MD, Mario Ferranti, MD, Luciano Giuliodori, MD, Marco Candela, MD, Monica Marconi, MD, Pietro Leoni, PhD
Journal: Blood
Blood (2006) 108 (11): 3566.
https://doi.org/10.1182/blood.V108.11.3566.3566
Published: 2006
Journal Articles

Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma

Clinical Trials & Observations
Massimo Offidani, Laura Corvatta, Maria-Novella Piersantelli, Giuseppe Visani, Francesco Alesiani, Marino Brunori, Piero Galieni, Massimo Catarini, Maurizio Burattini, Riccardo Centurioni, Mario Ferranti, Serena Rupoli, Anna Rita Scortechini, Luciano Giuliodori, Marco Candela, Debora Capelli, Mauro Montanari, Attilio Olivieri, Antonella Poloni, Claudia Polloni, Monica Marconi, Pietro Leoni
Journal: Blood
Blood (2006) 108 (7): 2159–2164.
https://doi.org/10.1182/blood-2006-03-013086
Published: 2006
Journal Articles

Thalidomide, Dexamethasone and Pegylated-Liposomal Doxorubicin (ThaDD) for Untreated Multiple Myeloma Patients Aged over 65 Years.

Massimo Offidani, MD, Laura Corvatta, MD, Monica Marconi, MD, Giuseppe Visani, MD, Francesco Alesiani, MD, Marino Brunori, MD, Piero Galieni, MD, Massimo Catarini, MD, Maurizio Burattini, MD, Riccardo Centurioni, MD, Serena Rupoli, MD, Anna Rita Scortechini, MD, Luciano Giuliodori, MD, Marco Candela, MD, Debora Capelli, MD, Mauro Montanari, MD, Attilio Olivieri, Ph. D., Maria-Novella Piersantelli, MD, Pietro Leoni, Ph. D.
Journal: Blood
Blood (2005) 106 (11): 2558.
https://doi.org/10.1182/blood.V106.11.2558.2558
Published: 2005